# A Study to Investigate the Concentrations of Zibotentan and Dapagliflozin in Blood When Given With and Without Food

> **NCT07404137** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 26 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Zibotentan/Dapagliflozin FDC

## Key facts

- **NCT ID:** NCT07404137
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-02-16
- **Primary completion:** 2026-04-02
- **Final completion:** 2026-04-02
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07404137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07404137, "A Study to Investigate the Concentrations of Zibotentan and Dapagliflozin in Blood When Given With and Without Food". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07404137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*